Всего подписок: 2, всего просмотров: 931
Оценка читателей: голосов 0
1. Grubbs H., Whitten R. A. Physiology, Active Immunity. StatPearls Publishing; Treasure Island (FL) 2018.
2. Belkaid Y., Harrison O. J. Homeostatic Immunity and the Microbiota. Immunity 2017, 46(4), 562–576.
3. Yang, Han. Z., Oppenheim J. J. Alarmins and immunity. Immunol Rev. 2017, 280(1), 41–56.
4. Tang J., Wu Z. Y., Dai R. J., Ma J., Gong G. Z. Hepatitis B virus-persistent infection and innate immunity defect: Cell-related or virus-related? World J. Clin. Cases 2018, 6(9), 233–241.
5. Man S. M. Infl ammasomes in the gastrointestinal tract: infection, cancer and gut microbiota homeostasis. Nat Rev Gastroenterol. Hepatol. 2018, 15(12), 721–737.
6. McGonagle D., Watad A., Savic S. Novel immunological based classifi cation of rheumatoid arthritis with therapeutic implications. Autoimmun. Rev. 2018, 17(11), 1115–1123.
7. Ozinsky A., Smith K. D., Hume D., Underhill D. M. Cooperative induction of pro-infl ammatory signaling by Toll-like receptors. J Endotoxin Res. 2000, 6(5), 393–396.
8. Patin E. C., Orr S. J., Schaible U. E. Macrophage inducible C-Type Lectin as a multifunctional player in immunity. Front. Immunol. 2017, 8, 861.
9. Elinav E., Strowig T., Henao-Mejia J., Flavell R. A. Regulation of the antimicrobial response by NLR proteins. Immunity 2011, 34, 665–679.
10. Liu Y., Olagnier D., Lin R. Host and Viral Modulation of RIG-I–Mediated Antiviral Immunity. Front. Immunol. 2017, 7, 662.
11. Poltorak A., He X., Smirnova I., Liu M. Y., Van H. C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282, 2085–2088.
12. Dziarski R. Recognition of bacterial peptidoglycan by the innate immune system. Cell Mol. Life Sci. 2003, 60(9), 1793–804.
13. Panaro M. A., Acquafredda A., Sisto M., Lisi. S, Maffione A. B., Mitolo V. Biological role of the N-formyl peptide receptors. Immunopharmacol. Immunotoxicol. 2006, 28, 103–127.
14. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato. S, Sanjo H., Matsumoto M., Hoshino K., Wagner H., Takeda K., Akira S. A Toll-like receptor recognizes bacterial DNA. Nature 2000, 408, 740–745.
15. Girardin S. E., Boneca I. G., Garneiro L. A., Antignac A., Jehanno M., Viala J., Tedin K., Labigne A., Zahringer U., Coyle A. J., DiStefano P. S., Bertin J., Sansonetti P. J., Philpott D. J. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 2003, 300, 1584–1587.
16. Girardin S. E., Boneca I. G., Viala J., Chamaillard M., Labigne A., Thomas G., Philpott D. J., Sansonetti P. J. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 2003, 278, 8869–8872.
17. Barnich N., Aguirre J. E., Reinecker H. C., Xavier R., Podolsky D. K. Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-{kappa}B activation in muramyl dipeptide recognition. J. Cell Biol. 2005, 170, 21–26.
18. Chen G., Shaw M. H., Kim Y. G., Nuñez G. NOD-like receptors: role in innate immunity and infl ammatory disease. Annu. Rev. Pathol. 2009, 4, 365–98.
19. Ростовцева Л. И., Андронова Т. М., Малькова В. П., Сорокина И. Б., Иванов В. Т. Синтез и противовопухолевое действие гликопептидов, содержащих N-ацетилглюкозаминил-(β1→4)-N-ацетилмурамил-дисахаридное звено. Биоорган. химия 1981, 7(12), 1843–1858. [Rostovtseva L. I., Andronova T. M., Mal’kova V. P., Sorokina I. B., Ivanov V. T. Synthesis and antitumor activity of glycopeptides containing N-acetylglucosaminyl-(β1→4)-N-acetylmuramyl disaccharide unit, Bioorg. Khim 1981, 7(12), 1843–1858.]
20. Ламан А. Г., Шепеляковская А. О., Бозиев Х. М., Савинов Г. В., Бровко Ф. А., Несмеянов В. А. Метод получения адъювантно активных пептидов – миметиков GMDP с использованием моноклональных антител и комбинаторных библиотек пептидов в формате фагового дисплея. Биоорган. химия 2010, 36(2), 170–177. [Laman A. G., Shepeliakovskaia A. O., Boziev Kh.M., Savinov G. V., Brovko F. A., Nesmeianov V. A. A method for the preparation of adjuvant peptide mimetics of GMDP with the use of monoclonal antibodies and combinatorial libraries of peptides in the format of phage display. Bioorg. Khim. 2010, 36(2), 170–177.]
21. Livak K. J., Schmittgen T. D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(–Delta Delta C(T)) Method. Methods 2001, 25(4), 402–408.
22. Pfaffl M. W. A new mathematical model for relative quantifi cation in real-time RT-PCR. Nucleic Acids Res. 2001, 29(9), e45.
23. Laman A. G., Shepelyakovskaya A. O., Boziev Kh. M., Savinov G. V., Baidakova L. K., Chulin A. N., Chulina I. A., Korpela T., Nesmeyanov V. A., Brovko F. A. Structural modifi cation eff ects on bioactivities of the novel 15-mer peptide adjuvant. Vaccine 2011, 29(44), 7779–7784.
24. Мещерякова Е. А., Гурьянова С. В., Макаров Е. А., Андронова Т. М., Иванов В. Т. Структурно-функциональное исследование глюкозаминилмурамоилпептидов. Влияние химической модификации N-ацетилглюкозаминил-N-ацетилмурамоилпептида на его иммуномодулирующие свойства in vivo и in vitro. Биоорган. химия 1991, 17(9), 1157–1165. [Meshcheryakova E. A., Guryanova S. V., Makarov E. A., Andronova T. M., Ivanov V. T. Structure-function investigation of glucosaminylmuramylpeptides. Infl uence of chemical modifi cation of the N-acetylglucosaminyl-N-acetylmuramyldipeptide (GMDP) on its immunomodulatory properties in vivo and in vitro. Bioorg. Khim. 1991, 17(9), 1157–1165.]
25. Fritz J. H., Girardin S. E., Fitting C., Werts C., Mengin-Lecreulx D., Caroff M., Cavaillon J. M., Philpott D. J., Adib-Conquy M. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists. Eur. J. Immunol. 2005, 35(8), 2459–2470.
26. Мещерякова Е. А., Алексеева Л. Г., Андронова Т. М. Роль мурамилпептидов в клеточной модели воспалительного иммунного ответа, Российский иммунологический журнал, 2015, 9(18), 3, 301–323. [Meshcheryakova E. A., Alekseeva L. G., Andronova T. M. The role of muramylpeptides in cellular model of inflammational immune response. Russian J. Immunol. 2015, 9(18), 3, 301–323.]
27. Concetti J., Wilson C. L. NFKB1 and Cancer: Friend or Foe? Cells 2018, 7(9), pii: E133.
28. Martinon F., Agostini L., Meylan E., Tschopp J. Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin infl ammasome. Curr. Biol. 2004, 14(21), 1929–1934.